SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001516551-21-000023
Filing Date
2021-12-16
Accepted
2021-12-16 18:43:52
Documents
3
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163969820618166.html 3  
1 FORM 3 wf-form3_163969820618166.xml 3 1732
2 211214 KEITH WARD POA a211215_kwxskyexbiox-xpo.htm EX-24 3709
3 211214 KEITH WARD POA a211215_kwxskyexbiox-xpo001.jpg GRAPHIC 246203
  Complete submission text file 0001516551-21-000023.txt   346301
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11217 JONAS RIDGE LANE RALEIGH NC 27613
Business Address
Ward Keith Wayne (Reporting) CIK: 0001662394 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55136 | Film No.: 211499092